1
|
Chang MA, Fouché B, LaFortune W, Holmes K, Rigodon J, Juin S, Marseille S, Rogier E, Green M, Kheradmand T, Moore SG, Gaul DA, Boncy J, Telfort MA. Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020. Am J Trop Med Hyg 2023; 108:1140-1144. [PMID: 37127264 PMCID: PMC10540108 DOI: 10.4269/ajtmh.22-0625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 02/26/2023] [Indexed: 05/03/2023] Open
Abstract
In 2018, a mass drug administration (MDA) campaign for malaria elimination was piloted in Haiti. The pilot treated 36,338 people with sulfadoxine-pyrimethamine (SP) and primaquine; no severe adverse events were detected. In 2020, another MDA campaign using the same medications was implemented to mitigate an upsurge in malaria cases during the COVID-19 pandemic. Four cases of Stevens-Johnson syndrome (SJS) were identified among the 42,249 people who took the medications. Three of these individuals required hospitalization; all survived. In addition to SP ingestion, an investigation of potential causes for increased SJS cases identified that all four cases had human leukocyte antigens A*29 and/or B*44:03, another known risk factor for SJS. Additionally, three of the four case individuals had antibodies to SARS-CoV-2, and the fourth may have been exposed around the same time. These findings raise the possibility that recent SARS-CoV-2 infection may have contributed to the increased risk for SJS associated with SP exposure during the 2020 campaign.
Collapse
Affiliation(s)
- Michelle A. Chang
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia
| | | | - Willy LaFortune
- Programme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti
| | - Kathleen Holmes
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Jonas Rigodon
- CDC-Haiti, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Port-au-Prince, Haiti
| | - Stanley Juin
- CDC-Haiti, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Port-au-Prince, Haiti
| | - Samson Marseille
- Laboratoire National de la Santé Publique, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti
| | - Eric Rogier
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Michael Green
- Entomology Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Taba Kheradmand
- Fred H. Allen Immunogenetics Laboratory, New York Blood Center, New York, New York
| | - Samuel G. Moore
- Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia
| | - David A. Gaul
- Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia
- School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
| | - Jacques Boncy
- Laboratoire National de la Santé Publique, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti
| | - Marc-Aurele Telfort
- Programme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti
| |
Collapse
|
2
|
Bashiri Aliabadi S, Haghani Dogahe Z, Feizkhah A, Mobayen M, Mirbolouk B. Management of Toxic Epidermal Necrolysis Using Early Combination Therapy of Intravenous Immunoglobulin and Amniotic Membrane Grafting: A Case Report. J Burn Care Res 2023; 44:467-470. [PMID: 36455871 DOI: 10.1093/jbcr/irac167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2022] [Indexed: 12/04/2022]
Abstract
Toxic epidermal necrolysis (TEN) is a devastating challenge faced by wound care practitioners. However, surgical management with amniotic membrane graft (AMG) promises better results in scar healing, but there is a lack of additional intervention to reduce the high mortality rate in those patients who are admitted with poor prognosis clinical situation. There is supportive evidence that combination therapy with AMG and early high-dose intravenous immunoglobulin (IVIG) as early management in TEN could improve the prognosis. In this study, the authors present a 61-year-old female who presented with a widespread macular lesion on the trunk, upper extremities, and face. The patient was treated with early amniotic membrane grafting and high-dose IVIG and achieved satisfactory results. Complete wound healing was achieved in 21 days. There were no acute or chronic complications, consisting of infection of the skin areas, gastrointestinal bleeding, pleural effusion, and severe ocular mucous membrane damage.
Collapse
Affiliation(s)
- Somaye Bashiri Aliabadi
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
| | - Zahra Haghani Dogahe
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
| | - Alireza Feizkhah
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.,Department of Medical Physics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
| | - Mohammadreza Mobayen
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran
| | - Batoul Mirbolouk
- Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.,Department of Medical Physiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
| |
Collapse
|
3
|
Ortega Beltrá N, Guallart Domenech F, Martínez Ruiz de Apodaca P, Pons Rocher F. Odynophagia as the first manifestation of toxic epidermal necrolysis. BMJ Case Rep 2022; 15:e250305. [PMID: 36423938 PMCID: PMC9693651 DOI: 10.1136/bcr-2022-250305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are infrequent mucocutaneous diseases, rapidly progressive and life-threatening. The clinical aspects and the management of TEN are exposed following a case.A man in his 40s presented to the emergency department with severe odynophagia, poor general condition and fever. His medical history was significant for HIV stage AIDS, and the treatment was discontinued 5 years before the present diagnosis. He was admitted for cerebral toxoplasmosis and discharged the previous 14 days with sulfadiazine. Erythematous-bullous lesions in the oral cavity, diffuse erythematous maculopapular rashes over his neck and chest, acute bilateral conjunctivitis and purulent urethritis was observed. The diagnostic suspicion was SJS/TEN due to sulfadiazine in immunosuppressed patients.This entity is infrequent but is a life-threatening dermatological emergency that requires immediate medical attention. Its diagnosis is mainly clinical, with a new drug history, prodromal symptoms and characteristic cutaneous-mucous lesions. Early diagnosis and rapid withdrawal of the drug improve the prognosis.
Collapse
Affiliation(s)
| | | | - Paula Martínez Ruiz de Apodaca
- Otorhinolaryngology, Hospital Universitario Doctor Peset, Valencia, Spain
- Otorhinolaryngology, Hospital Universitario Doctor Peset, Valencia, Spain
| | - Francisco Pons Rocher
- Otorhinolaryngology, Hospital Universitario Doctor Peset, Valencia, Spain
- Cirurgia (Otorhinolaryngology), Universitat de Valencia Facultat de Medicina i Odontologia, Valencia, Spain
| |
Collapse
|
4
|
Sljivic S, Pogson K, Williams FN, Nizamani R, King BT. COVID-induced toxic epidermal necrolysis in a 4-year-old female: a case report and literature review. INTERNATIONAL JOURNAL OF BURNS AND TRAUMA 2022; 12:204-209. [PMID: 36420101 PMCID: PMC9677226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 08/28/2022] [Indexed: 12/24/2022]
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are conditions characterized by an immune-mediated skin reaction that results in blistering and epidermal detachment. Most cases are caused by drug hypersensitivity; however, recently there have been many publications documenting the association between coronavirus disease 2019 (COVID-19) and SJS/TEN. Our objective is to explore a case of a 4-year-old female who presented with a papular rash on her thighs that progressively worsened and spread to her face, trunk, and genital area. The patient tested positive for COVID-19. She required treatment with intravenous immunoglobulin (IVIG) and IV methylprednisolone, but eventually made a full recovery. This case underscores the need for awareness of the wide spectrum of dermatologic presentations in COVID-19 patients.
Collapse
Affiliation(s)
- Sanja Sljivic
- Department of Surgery, University of North Carolina School of MedicineChapel Hill, NC, USA,North Carolina Jaycee Burn CenterChapel Hill, NC, USA
| | - Kaylyn Pogson
- University of North Carolina School of MedicineChapel Hill, NC, USA
| | - Felicia N Williams
- Department of Surgery, University of North Carolina School of MedicineChapel Hill, NC, USA,North Carolina Jaycee Burn CenterChapel Hill, NC, USA
| | - Rabia Nizamani
- Department of Surgery, University of North Carolina School of MedicineChapel Hill, NC, USA,North Carolina Jaycee Burn CenterChapel Hill, NC, USA
| | - Booker T King
- Department of Surgery, University of North Carolina School of MedicineChapel Hill, NC, USA,North Carolina Jaycee Burn CenterChapel Hill, NC, USA
| |
Collapse
|
5
|
Severe Acute Respiratory Syndrome Coronavirus 2–Associated Blepharoconjunctivitis and Erythema Multiforme-Like Rash in a Young Man. Cornea 2022; 41:1568-1571. [DOI: 10.1097/ico.0000000000002848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Accepted: 06/23/2021] [Indexed: 11/27/2022]
|
6
|
Manciuc C, Lacatusu GA, Vata A, Sapaniuc C, Arteni CM, Petrariu FD. Concomitance or consequence? Stevens-Johnson syndrome in COVID-19: A case report. Exp Ther Med 2022; 23:257. [PMID: 35261629 PMCID: PMC8855504 DOI: 10.3892/etm.2022.11182] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 12/17/2021] [Indexed: 01/09/2023] Open
Abstract
The novel coronavirus infection has been, and still is, a pressing medical problem with a catastrophic effect, not only from a medical point of view, but also from an economic and social one. The cutaneous manifestations of the disease have a diverse morphology and can signal the presence of the infection. The present article reports the case of a 77-year-old male patient admitted at The Sf. Parascheva Clinical Hospital of Infectious Diseases in Iasi (Romania) after testing positive for SARS CoV-2 infection. Initially, the patient presented a pruriginous generalized maculopapular-erythematous eruption with a tendency towards confluence, peri-oro-nasal meliceric crusts and desquamation of the skin on the third anterosuperior and posterior thorax, scalp and forehead, which was accompanied by low back pain, headache and orbital pain. The suspicion of Stevens-Johnson syndrome (SJS) was raised, and treatment was given according to the recommendation of the hospital dermatologist. This association raises multiple questions regarding whether SJS is a cutaneous manifestation of COVID-19 or if there was a concomitance between the viral infection and the immune reaction. The combination of SJS and COVID-19 can have a fatal outcome if not recognized and promptly treated. To our knowledge, this is the first case of SJS in a patient diagnosed with SARS CoV-2 infection in Romania.
Collapse
Affiliation(s)
- Carmen Manciuc
- Department of Infectious Diseases, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Georgiana Alexandra Lacatusu
- Department of Infectious Diseases, Sf. Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania,Correspondence to: Dr Georgiana Alexandra Lacatusu, Department of Infectious Diseases, Sf. Parascheva Clinical Hospital of Infectious Diseases, Str. Octav Botez 2, 700116 Iasi, Romania
| | - Andrei Vata
- Department of Infectious Diseases, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
| | - Cristina Sapaniuc
- Department of Infectious Diseases, Sf. Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania
| | - Carmen Mihaela Arteni
- Department of Infectious Diseases, Sf. Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania
| | - Florin Dumitru Petrariu
- Department of Preventive Medicine and Interdisciplinary, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
| |
Collapse
|
7
|
Jouhar L, Yahya M, Elsiddiq S. Toxic Epidermal Necrolysis associated with COVID‐19 infection: A case report. Clin Case Rep 2022; 10:e05565. [PMID: 35310321 PMCID: PMC8918465 DOI: 10.1002/ccr3.5565] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2021] [Revised: 02/11/2022] [Accepted: 02/25/2022] [Indexed: 12/19/2022] Open
Abstract
Toxic Epidermal Necrolysis/Steven–Johnson Syndrome (TEN/SJS) is one of the most serious dermatological adverse reactions triggered mainly by drugs and less likely by infections. COVID‐19 disease is caused by Sever Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) with a wide range of clinical manifestations. Skin involvement is common in COVID‐19 patients including urticaria, purpura, and vasculitis. There were reported cases of TEN/SJS in adults with COVID‐19 infections and only two reported cases in pediatric patients. The causality relationship between COVID‐19 infection and TEN/SJS was not established in most cases due to history of drug usage that could be the trigger. In this study, we are reporting a case of previously healthy child apart from COVID‐19 infection who was admitted to the intensive care unit with TEN involving more than 30% of body surface area confirmed by skin biopsy. The child was treated with intravenous immunoglobulins, steroids, and cyclosporin with a very good outcome.
Collapse
Affiliation(s)
- Lamia Jouhar
- Department of Pediatrics Hamad Medical Corporation Doha Qatar
| | - Marva Yahya
- Department of Pediatrics Hamad Medical Corporation Doha Qatar
| | - Sohair Elsiddiq
- Department of Pediatrics Hamad Medical Corporation Doha Qatar
| |
Collapse
|
8
|
Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study. Am J Clin Dermatol 2022; 23:257-266. [PMID: 35119606 PMCID: PMC8814784 DOI: 10.1007/s40257-021-00661-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/21/2021] [Indexed: 12/20/2022]
Abstract
OBJECTIVE Our objective was to describe the incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) in a large unselected cohort, to validate the culprit drugs involved and the frequency of SJS/TEN for each drug, and to analyze the clinical risk factors for SJS/TEN. METHODS Using the computerized database of Clalit Health Services, we identified all adult patients with a new SJS/TEN diagnosis between 1 January, 2008 and 30 June, 2019 and validated each case. Cumulative incidence of SJS/TEN for each culprit drug was calculated by dividing the number of valid cases by the total number of new users of the drug in the study period. Using risk-set sampling, 20 controls were matched to each case by sex and age on the index date for a nested case-control analysis. Multivariable conditional logistic regression was used to estimate the odds ratio and 95% confidence interval for the association of incident SJS/TEN with chronic diseases. RESULTS We identified 87 adult cases of true/probable SJS/TEN between 1 January, 2008 and 30 June, 2019. Culprit drugs [with ALDEN scores ascertained as at least probable (≥ 4)] associated with the highest absolute risks were phenytoin, lamotrigine, and allopurinol with 3.56, 2.82, and 1.10 SJS/TEN cases/10,000 new users, respectively. Additional drugs with mean ALDEN scores ≥ 4 were sunitinib, sulfasalazine, carbamazepine, etoricoxib, etodolac, and cefuroxime, cumulative incidence: 13.57, 0.72, 0.32, 0.05, 0.02, and 0.02/10,000 new users, respectively. Previous diagnosis of systemic lupus erythematosus, psoriasis, previous drug allergies, epilepsy, malignancy, history of cerebrovascular accident, and history of diabetes mellitus were associated with an increased risk for SJS/TEN, odds ratios (95% confidence interval):17.41 (1.31-230.72), 10.28 (3.61-29.31), 5.21 (2.95-9.19), 4.92 (1.88-12.85), 3.17 (1.77-5.66), 2.61 (1.26-5.41), and 1.98 (1.12-3.53), respectively. CONCLUSIONS Attention should be drawn to drugs assessed by high ALDEN scores that were associated with high absolute risks for SJS/TEN. Psoriasis, former drug allergies, in addition to systemic lupus erythematosus, malignancy, history of cerebrovascular accident, and diabetes mellitus were associated with increased SJS/TEN risk in our analysis.
Collapse
|
9
|
Yang W, Xu X, Xia D, Wang H, Jiang J, Yang G. Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature review. Immunotherapy 2022; 14:275-282. [PMID: 35128931 DOI: 10.2217/imt-2021-0074] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Aim: The emergence of antitumor immunotherapy has been beneficial for patients with tumors, but more attention should be paid to the toxic side effects of chemoimmunotherapy. Here we describe a patient with NK/T-cell lymphoma who developed toxic epidermal necrolysis (TEN) during treatment with a regimen consisting of sintilimab combined with pegaspargase, gemcitabine and oxaliplatin (P-GemOx). Case presentation: A patient received six cycles of P-GemOx chemotherapy as first-line treatment; 1 year later, he received the same dose of P-GemOx combined with sintilimab as chemoimmunotherapy due to recurrence of NK/T-cell lymphoma. He developed a massive rash that quickly developed into TEN after the fourth chemoimmunotherapy. Conclusion: Although rare, cases of fatal TEN caused by single-agent PD-1 inhibitor or gemcitabine have been reported. Careful attention to drug-related cutaneous toxicities is needed when these two agents are combined. This report highlights the significance of TEN as a rapid and serious adverse event induced by chemoimmunotherapy.
Collapse
Affiliation(s)
- Wei Yang
- Department of Oncology, Hangzhou Red Cross Hospital, Hangzhou, China
| | - Xiaofeng Xu
- Department of Hematology, Hangzhou Red Cross Hospital, Hangzhou
| | - Dajing Xia
- Department of Toxicology of School of Public Health, & Center of Immunology & Infection, School of Medicine, Zhejiang University, Hangzhou, China
| | - Huaichong Wang
- Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou, China
| | - Jing Jiang
- Department of Oncology, Hangzhou Red Cross Hospital, Hangzhou, China
| | - Guoliang Yang
- Department of Hematology, Hangzhou Red Cross Hospital, Hangzhou
| |
Collapse
|
10
|
Mitamura Y, Schulz D, Oro S, Li N, Kolm I, Lang C, Ziadlou R, Tan G, Bodenmiller B, Steiger P, Marzano A, Prost N, Caudin O, Levesque M, Stoffel C, Schmid‐Grendelmeier P, Maverakis E, Akdis CA, Brüggen M. Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients. Allergy 2022; 77:595-608. [PMID: 34157151 PMCID: PMC8441838 DOI: 10.1111/all.14983] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 06/03/2021] [Accepted: 06/10/2021] [Indexed: 02/07/2023]
Abstract
Background Coronavirus disease‐2019 (COVID‐19) has been associated with cutaneous findings, some being the result of drug hypersensitivity reactions such as maculopapular drug rashes (MDR). The aim of this study was to investigate whether COVID‐19 may impact the development of the MDR. Methods Blood and skin samples from COVID‐19 patients (based on a positive nasopharyngeal PCR) suffering from MDR (COVID‐MDR), healthy controls, non‐COVID‐19—related patients with drug rash with eosinophilia and systemic symptoms (DRESS), and MDR were analyzed. We utilized imaging mass cytometry (IMC) to characterize the cellular infiltrate in skin biopsies. Furthermore, RNA sequencing transcriptome of skin biopsy samples and high‐throughput multiplexed proteomic profiling of serum were performed. Results IMC revealed by clustering analyses a more prominent, phenotypically shifted cytotoxic CD8+ T cell population and highly activated monocyte/macrophage (Mo/Mac) clusters in COVID‐MDR. The RNA sequencing transcriptome demonstrated a more robust cytotoxic response in COVID‐MDR skin. However, severe acute respiratory syndrome coronavirus 2 was not detected in skin biopsies at the time point of MDR diagnosis. Serum proteomic profiling of COVID‐MDR patients revealed upregulation of various inflammatory mediators (IL‐4, IL‐5, IL‐6, TNF, and IFN‐γ), eosinophil and Mo/Mac ‐attracting chemokines (MCP‐2, MCP‐3, MCP‐4 and CCL11). Proteomics analyses demonstrated a massive systemic cytokine storm in COVID‐MDR compared with the relatively milder cytokine storm observed in DRESS, while MDR did not exhibit such features. Conclusion A systemic cytokine storm may promote activation of Mo/Mac and cytotoxic CD8+ T cells in severe COVID‐19 patients, which in turn may impact the development of MDR.
Collapse
Affiliation(s)
| | - Daniel Schulz
- Institute for Molecular Health SciencesETH Zurich Zurich Switzerland
- Department of Quantitative Biomedicine University of Zurich Zurich Switzerland
| | - Saskia Oro
- Department of Dermatology Henri Mondor Hospital Paris France
| | - Nick Li
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Isabel Kolm
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Claudia Lang
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Reihane Ziadlou
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Ge Tan
- Swiss Institute for Allergy Research (SIAF) Davos Davos Switzerland
| | - Bernd Bodenmiller
- Institute for Molecular Health SciencesETH Zurich Zurich Switzerland
- Department of Quantitative Biomedicine University of Zurich Zurich Switzerland
| | - Peter Steiger
- Faculty of Medicine University Zurich Zurich Switzerland
- Department of Intensive Care Medicine University Hospital Zurich Zurich Switzerland
| | - Angelo Marzano
- Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
- Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy
| | - Nicolas Prost
- Department of Dermatology Henri Mondor Hospital Paris France
| | - Olivier Caudin
- Department of Dermatology Henri Mondor Hospital Paris France
| | - Mitchell Levesque
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Corinne Stoffel
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
| | - Peter Schmid‐Grendelmeier
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
- Christine Kühne‐Center for Allergy Research and Education Davos Switzerland
| | - Emanual Maverakis
- Department of Dermatology University of California, Davis Sacramento CA USA
| | - Cezmi A. Akdis
- Swiss Institute for Allergy Research (SIAF) Davos Davos Switzerland
- Christine Kühne‐Center for Allergy Research and Education Davos Switzerland
| | - Marie‐Charlotte Brüggen
- Department of Dermatology University Hospital Zurich Zurich Switzerland
- Faculty of Medicine University Zurich Zurich Switzerland
- Christine Kühne‐Center for Allergy Research and Education Davos Switzerland
| |
Collapse
|
11
|
Sarangal R, Aulakh S, Arora R, Chopra D. Increased predisposition of sjs ten in COVID-19 patients, presenting as post COVID complication: Report of two cases. Indian Dermatol Online J 2022; 13:237-239. [PMID: 35287406 PMCID: PMC8917493 DOI: 10.4103/idoj.idoj_510_21] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 09/18/2021] [Accepted: 09/19/2021] [Indexed: 11/16/2022] Open
Abstract
We report two consecutive cases of toxic epidermal necrolysis presented to our emergency department in the past 5 months. Both patients had history of fever prior to the onset of skin manifestations and showed radiological findings suggestive of COVID-19 pneumonia and elevated D dimers. ALDEN score was used to assess the drug causality, which showed probable and possible associations, respectively. In this report, along with brief review of literature, we highlight the possible role of viral etiology, that is SARS-Cov2, in triggering toxic epidermal necrolysis.
Collapse
|
12
|
Shiohara T, Mizukawa Y. Ask Not What AI Can Do to Us, but What We Can Do with AI. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2022; 10:284-285. [PMID: 35000736 DOI: 10.1016/j.jaip.2021.10.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 10/20/2021] [Indexed: 06/14/2023]
Affiliation(s)
- Tetsuo Shiohara
- Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
| | - Yoshiko Mizukawa
- Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
| |
Collapse
|
13
|
Khaliullina SV, Anokhin VA, Sadykova DI, Makarova TP, Samoylova NV, Melnikova YS, Nazarova OA, Gumarova TV, Alatyrev EY, Vinnikov AM, Ziyatdinova LM. Post-covid syndrome in children. ROSSIYSKIY VESTNIK PERINATOLOGII I PEDIATRII (RUSSIAN BULLETIN OF PERINATOLOGY AND PEDIATRICS) 2021. [DOI: 10.21508/1027-4065-2021-66-5-188-193] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Multisystem inflammatory syndrome in children associated with COVID-19 is a new disease, information first appeared in April 2020. There were reported cases of hospitalized children with unusual symptoms, manifested primarily by fever and multisystem inflammation from the pediatricians in the UK and other countries during the coronavirus infection pandemic (COVID-19). Some of these children were in critical condition with symptoms of shock and multiple organ failure, and some children had manifestations similar to Kawasaki disease. Despite the fact that COVID-19 in children is relatively easy, some of the «convalescents» after 2–6 weeks develop symptoms largely identical to the manifestations of severe forms of new coronavirus infection in adults. The report presents own clinical cases of multisystem inflammatory syndrome that developed in children after acute form of a new coronavirus infection. The authors discuss the possible clinical variants of the syndrome, its origin and outcomes.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - T. V. Gumarova
- Agafonova Republican Clinical Infectious Diseases Hospital
| | | | - A. M. Vinnikov
- Agafonova Republican Clinical Infectious Diseases Hospital
| | | |
Collapse
|
14
|
Al-Hadidi SH, Alhussain H, Abdel Hadi H, Johar A, Yassine HM, Al Thani AA, Eltai NO. The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review. Microb Drug Resist 2021; 27:1705-1725. [PMID: 34077290 PMCID: PMC8713256 DOI: 10.1089/mdr.2020.0619] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Objectives: Over the last decades, there has been a significant increase in antimicrobial prescribing and consumption associated with the development of patients' adverse events and antimicrobial resistance (AMR) to the point of becoming a global priority. This study aims at evaluating antibiotic prescribing during COVID-19 pandemic from November 2019 to December 2020. Materials and Methods: A systematic review was conducted primarily through the NCBI database, using PRISMA guidelines to identify relevant literature for the period between November 1, 2019 and December 19, 2020, using the keywords: COVID-19 OR SARS-Cov-2 AND antibiotics restricted to the English language excluding nonclinical articles. Five hundred twenty-seven titles were identified; all articles fulfilling the study criteria were included, 133 through the NCBI, and 8 through Google Scholar with a combined total of 141 studies. The patient's spectrum included all ages from neonates to elderly with all associated comorbidities, including immune suppression. Results: Of 28,093 patients included in the combined studies, 58.7% received antibiotics (16,490/28,093), ranging from 1.3% to 100% coverage. Antibiotics coverage was less in children (57%) than in adults with comorbidities (75%). Broad-spectrum antibiotics were prescribed presumptively without pathogen identifications, which might contribute to adverse outcomes. Conclusions: During the COVID-19 pandemic, there has been a significant and wide range of antibiotic prescribing in patients affected by the disease, particularly in adults with underlying comorbidities, despite the paucity of evidence of associated bacterial infections. The current practice might increase patients' immediate and long-term risks of adverse events, susceptibility to secondary infections as well as aggravating AMR.
Collapse
Affiliation(s)
| | | | - Hamad Abdel Hadi
- Infectious Disease Division, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar
| | | | | | | | - Nahla O. Eltai
- Biomedical Research Center, Qatar University, Doha, Qatar
| |
Collapse
|
15
|
Corona virus disease 2019-associated Stevens-Johnson syndrome: a case report. BMC Ophthalmol 2021; 21:274. [PMID: 34253167 PMCID: PMC8273563 DOI: 10.1186/s12886-021-02033-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Accepted: 07/06/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND To report Stevens-Johnson syndrome (SJS) in a patient with acute pneumonia secondary to SARS-CoV-2 infection. CASE PRESENTATION A 45-years-old woman with a diagnosis of acute pneumonia secondary to SARS-CoV-2 infection who had received azithromycin and naproxen. Three days after starting the medication, she appeared ill and developed ocular discomfort, photophobia, dysuria, and macular rashes on the trunk and the extremities. On ophthalmological examination, a total epithelial defect was seen in both eyes. According to the examination, Stevens-Johnson syndrome was diagnosed and the patient was admitted to receive systemic and ocular support and medical care. The patient's condition improved during the 3 weeks and recovered from both COVID-19 and SJS life-threatening complications but ocular complications, including the destruction of the meibomian glands, irregularity of the eyelid margin, and corneal scarring remained for the patient. CONCLUSIONS Although, it is not clear whether the cause of Stevens-Johnson syndrome in COVID-19 patients is the virus itself or whether the use of medication, but patients with COVID-19, especially patients receiving medication, should be screened for symptoms of Stevens-Johnson syndrome.
Collapse
|
16
|
Parietti M, Siliquini N, Ortoncelli M, Dapavo P, Stella M, Verrua R, Ribero S, Quaglino P. Toxic epidermal necrolysis and role of immune dysregulation in a patient affected by coronavirus disease. Ital J Dermatol Venerol 2021; 156:498-499. [PMID: 34044512 DOI: 10.23736/s2784-8671.21.07011-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Michele Parietti
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
| | - Niccolò Siliquini
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
| | - Michela Ortoncelli
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
| | - Paolo Dapavo
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
| | - Maurizio Stella
- Department of General and Specialized Surgery, Plastic Surgery, Burn Center and Skin Bank, Turin, Italy
| | - Roberta Verrua
- Department of General and Specialized Surgery, Plastic Surgery, Burn Center and Skin Bank, Turin, Italy
| | - Simone Ribero
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy -
| | - Pietro Quaglino
- Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy
| |
Collapse
|
17
|
Narang I, Panthagani AP, Lewis M, Chohan B, Ferguson A, Nambi R. COVID-19-induced toxic epidermal necrolysis. Clin Exp Dermatol 2021; 46:927-929. [PMID: 33511662 PMCID: PMC8014080 DOI: 10.1111/ced.14574] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Accepted: 01/26/2021] [Indexed: 01/21/2023]
Affiliation(s)
- I Narang
- Department of, Department of, Dermatology, University Hospitals of Derby and Burton, Derby, UK
| | - A P Panthagani
- Department of, Department of, Dermatology, University Hospitals of Derby and Burton, Derby, UK
| | - M Lewis
- Department of, Palliative Medicine, University Hospitals of Derby and Burton, Derby, UK
| | - B Chohan
- Department of, Pathology, University Hospitals of Derby and Burton, Derby, UK
| | - A Ferguson
- Department of, Department of, Dermatology, University Hospitals of Derby and Burton, Derby, UK
| | - R Nambi
- Department of, Department of, Dermatology, University Hospitals of Derby and Burton, Derby, UK
| |
Collapse
|
18
|
Tanaka A, Isei M, Kikuzawa C, Hinogami H, Nishida K, Gohma I, Ogawa Y. Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA. J Dermatol 2021; 48:e144-e145. [PMID: 33439527 PMCID: PMC8014636 DOI: 10.1111/1346-8138.15753] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Revised: 12/01/2020] [Accepted: 12/15/2020] [Indexed: 01/12/2023]
Affiliation(s)
- Aya Tanaka
- Department of Dermatology, Sakai City Medical Center, Sakai, Japan
| | - Moeko Isei
- Department of Dermatology, Sakai City Medical Center, Sakai, Japan
| | - Chiaki Kikuzawa
- Department of Dermatology, Sakai City Medical Center, Sakai, Japan
| | - Haruna Hinogami
- Department of Dermatology, Sakai City Medical Center, Sakai, Japan
| | - Koji Nishida
- Department of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan
| | - Iwao Gohma
- Department of Respiratory Medicine, Sakai City Medical Center, Sakai, Japan
| | - Yoshihiko Ogawa
- Department of Infectious Diseases, Sakai City Medical Center, Sakai, Japan
| |
Collapse
|
19
|
Multiple drugs. REACTIONS WEEKLY 2020. [PMCID: PMC7644979 DOI: 10.1007/s40278-020-85438-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|